A randomized trial of etanercept as monotherapy for psoriasis
AB Gottlieb, RT Matheson, N Lowe… - Archives of …, 2003 - jamanetwork.com
Objective To determine safety and efficacy of monotherapy with etanercept. Design
Randomized, double-blind, placebo-controlled, multicenter study. Setting Outpatient,
ambulatory; private practice and university dermatology research centers. Patients Patients
aged at least 18 years, with plaque psoriasis involving 10% or more of body surface area;
148 were screened and 112 were randomly assigned to treatment groups and received
study drug. Interventions Patients received placebo or etanercept, 25 mg, subcutaneously …
Randomized, double-blind, placebo-controlled, multicenter study. Setting Outpatient,
ambulatory; private practice and university dermatology research centers. Patients Patients
aged at least 18 years, with plaque psoriasis involving 10% or more of body surface area;
148 were screened and 112 were randomly assigned to treatment groups and received
study drug. Interventions Patients received placebo or etanercept, 25 mg, subcutaneously …